Navigation Links
Death Risk Of Ovarian Cancer Reduced By Intraperitoneal Chemotherapy

Direct injection of chemotherapeutic agents into directly into the body cavity rather than the conventional intravenous route, seems to be // associated with an improved prognosis of ovarian cancer patients, according to a latest study. //

Ovarian cancer is the fourth leading cause of death among American women. In line with the above finding, the US government has recommended this new form of treatment for all ovarian cancer patients.

This new treatment modality can be difficult to tolerate, but promises an improved average survival rate of nearly 16 months and a 25% reduction in the associated death risk. The results of this study represent one of the largest benefits ever observed for a new therapy in gynecologic oncology, in the opinion of Stephen Cannistra, editor of the New England Journal of Medicine.

"It's very good news. A lot of larger institutions have already adopted this approach. At least for today, this is the best thing we can offer our patients ", said Deborah Armstrong, chief author of the study.

The only surgical option left for patients with advanced ovarian cancer is the removal of most of the visible tumor followed by infusion of chemotherapeutic agents. Most women who receive this form of treatment die within two to three years.

Researchers at the Johns Hopkins Kimmel Cancer Center initiated a study, in an attempt to change the condition. 415 patients with an ovarian cancer diagnosis were taken up for the study. Among the participants, 210 received standard chemotherapy with cisplatin and paclitaxel, while another 205 received the new form of treatment.

The chemotherapeutic agent was directly injected into the body cavity, along with sterile water in such a way that it flushed the entire peritoneum. This was repeated another five times, with a minimum duration of three weeks between each session. It was found that these women survived for 66 months that meant a 32% improvement in the survival rate compared to their counterparts.

Adverse effects such as pain, tiredness and other problems associated with the stomach and intestine were observed, which hindered continuation of the therapy in 58% of the patients. This was however much higher compared to the intravenous group where, the quit rate was only 17%.

Following the promising findings, it has been recommended by the National Cancer Institute to deliver chemotherapy drugs both directly into the abdomen and intravenously following surgery for ovarian cancer.

Intraperitoneal chemotherapy, as the technique is called, "allows higher doses and more frequent administration of drugs, and it appears to be more effective in killing cancer cells in the peritoneal cavity, where ovarian cancer is likely to spread or recur first," said the National Institutes of Health.


'"/>




Related medicine news :

1. White Cells Count Can Predict Heart Attack Death Risk
2. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
3. AIDS toll set to exceed Black Death
4. Fish Oil Fights Arrhythmias, Sudden Death
5. Painkiller Linked to Deaths
6. Death due to premature heartbeat after exercise
7. Preventing Childhood Deaths
8. Death Risk Higher in Obese Women with Colon Cancer
9. Death Among the Homeless
10. Diabetes on the Increase but Death Rate Falling
11. Drug Users and Risk of Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
Breaking Medicine Technology: